China Registration Study in Patients With Skin Infections

PHASE3CompletedINTERVENTIONAL
Enrollment

265

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

September 30, 2010

Study Completion Date

September 30, 2010

Conditions
Skin DiseasesInfectious
Interventions
DRUG

Daptomycin

4mg/kg IV ; Q 24 hr (once every 24 hours)

DRUG

Vancomycin

"Vancomycin - 1g per 12 hrs, for 7-14 days~Or switch to~Vancomycin Followed by Semi-synthetic Penicillin-Cloxacillin:~\- 1 g every 6 hours or 2 g every 8 hours"

Trial Locations (13)

Unknown

Research Site, Beijing

Research Site, Guangzhou

Research Site, Wuhan

Research Site, Changsha

Research Site, Nanjing

Research Site, Suzhou

Research Site, Shenyang

Research Site, Shanghai

Research Site, Chengdu

Research Site, Chongqing

Research Site, Dalian

Research Site, Hangzhou

Research Site, Qingdao

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY